Literature DB >> 22375523

Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma.

Robert G Gish1, Riccardo Lencioni, Adrian M Di Bisceglie, Jean-Luc Raoul, Vincenzo Mazzaferro.   

Abstract

It has long been appreciated that hepatocellular carcinoma (HCC) is a complex disease. HCC is typically preceded by liver cirrhosis, which is itself caused by various types of hepatitis of both viral and nonviral etiologies. Thus, the treatment of patients with HCC requires multiple healthcare professionals, including hepatologists, medical oncologists, surgical oncologists, transplantation surgeons, diagnostic radiologists, pathologists, nurses, nurse practitioners and interventional radiologists. These specialists should meet regularly to review patients' progress, ensure that treatments are individualized for each patient and agree on next steps. We review case presentations provided by the authors to illustrate the benefits and advantages of the multidisciplinary team matrix in the management of patients with HCC, including the effects of this treatment technique on patient outcome, survival and quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22375523     DOI: 10.1586/egh.11.105

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  26 in total

Review 1.  Multidisciplinary management of patients with cirrhosis: a need for care coordination.

Authors:  Jessica L Mellinger; Michael L Volk
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-06       Impact factor: 11.382

Review 2.  Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults.

Authors:  Christopher D Woodrell; Lissi Hansen; Thomas D Schiano; Nathan E Goldstein
Journal:  Clin Ther       Date:  2018-03-20       Impact factor: 3.393

3.  Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Stefano Merolla; Simona Francioso; Costantino Del Giudice; Mario Angelico; Giuseppe Tisone; Giovanni Simonetti
Journal:  World J Hepatol       Date:  2015-06-28

Review 4.  Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.

Authors:  Marco Vivarelli; Roberto Montalti; Andrea Risaliti
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 5.  Chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

6.  Multidisciplinary team approach to end-stage dialysis access patients.

Authors:  Clark Kensinger; Evan Brownie; Peter Bream; Derek Moore
Journal:  J Surg Res       Date:  2015-05-06       Impact factor: 2.192

Review 7.  Chemoembolization of hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Pasquale Petruzzi; Laura Crocetti
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 8.  Hepatic resection beyond barcelona clinic liver cancer indication: When and how.

Authors:  Mattia Garancini; Enrico Pinotti; Stefano Nespoli; Fabrizio Romano; Luca Gianotti; Vittorio Giardini
Journal:  World J Hepatol       Date:  2016-04-18

9.  Intermediate hepatocellular carcinoma: the role of transarterial therapy.

Authors:  Fabrizio Chegai; Antonio Orlacchio; Stefano Merolla; Serena Monti; Lorenzo Mannelli
Journal:  Hepat Oncol       Date:  2015-10

10.  Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Silvia Roma; Stefano Merolla; Alessandra Bosa; Simona Francioso
Journal:  Radiol Med       Date:  2019-10-03       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.